Our vision is panoramic. Experience breast imaging intelligence that transcends the past, present and future. Create a patient journey that is truly personalized and raise the bar on detection performance - with ProFound AI. Discover iCAD Breast Health Solutions adopted in more than 6,500 facilities worldwide. Learn more below:

Discover
ProFound AI for DBT
Discover ProFound AI
for 2D Mammography
NEW!
ProFound AI Risk

Book a Meeting

Achieve superior performance with ProFound AI® for DBT1-2

Superior Performance and Superior Sensitivity

ProFound AI® for DBT became the first artificial intelligence (AI) software for DBT, or 3D mammography, FDA-cleared and CE Marked in 2018Trained on over 20,000 cases, including over 7,000 cancers. Algorithm continuously evolving and improving.ProFound AI® for DBTRadiologist Benefits8% improvement in sensitivity7% reduction in rate of recalls52.7% reduction in reading time for radiologistsMulti-vendor compatibilityNow compatible with Hologic Clarity HD,* Fujifilm Amulet Innovality* and all top digital breast tomosynthesis systems.

NEW! Clinical
Performance Benefits**
3rd Gen Accelerating Performance
Coming Soon
Enhances breast cancer screening with a specificity performance improvement of up to 10%
Workflow
Benefits
Certainty of Finding scores assist in prioritizing caseload and clinical decision-making may help to reduce physician burnout

*CE Mark countries only.  **FDA Clearance Pending

Advanced Breast Cancer Detection Solutions for FFDM Imaging*

ProFound AI® for 2D Mammography

Precise. Powerful. Proven.

World-class artificial intelligence for 2D mammography. The high-performing cancer detection and workflow solution rapidly and accurately analyzes each image, detecting both malignant soft tissue densities and calcifications with unrivaled accuracy.

Workflow Benefits

AI algorithm with superior performance for the detection of breast cancer and high specificity with low numbers of false positivesCertainty of Findings and Case Scores to assist in clinical decision-making and prioritizing caseloadsWorkflow solution that renders quick results while analyzing each image for detections

*CE Mark countries only. Not available for sale in the U.S.

New! Stratify your patients for screening with ProFound AI® Risk

New and now available in the US and EU! ProFound AI® Risk is the first and only clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that is truly personalized for each woman, based only on a screening mammogram. The easy-to-implement solution provides superior insights that empower clinicians to tailor a woman’s breast screening regimen and potentially identify cancers earlier.

Superior AccuracyAn AUC of 0.73 offers superior accuracy compared to traditional risk assessment models.3Simplified WorkflowEfficient and easy to implement solution provides a rapid short-term risk estimate based on the mammographic exam.Personalized CareImproved model delivers operational efficiency and enhances patient care.

CE Marked.

We believe radiologists say it best. Hear about the Power of ProFound AI from leading clinical experts.

Engage with us anytime, anywhere at virtual RSNA.

Visit our BoothWe invite you to visit our virtual booth and explore our Breast Health Solutions. Visit us when the show opens November 29th.Learn More>Attendee RegistrationNot already registered for RSNA 2020? Join us to learn more about the power of ProFound AI and the proven experts behind our innovative technology.Learn More>Discover the iCAD virtual ExperienceNot attending RSNA this year? There are many ways to stay connected with iCAD. Book a virtual meeting with one of our experts today!Learn More>

Register for a meeting during virtual RSNA for a chance to win an Apple Watch.

References:

  1. K182373
  2. Conant E, et al. Radiology: Artificial Intelligence 2019;1(4):e180096.
  3. Eriksson M, Czene K, Strand F, et al. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening. [published online ahead of print September 8, 2020]. Radiology. Accessed via https://doi.org/10.1148/radiol.2020201620

© 2020, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.